ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,153Medicare Part D Prescriptions Filled, Including Refills

Rank: 265 out of 676

$355K Total Retail Price of All Prescriptions

Rank: 301 out of 676

387 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 6,835 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 365 285 1 3
OMEPRAZOLE 300 245 2 2
SYNTHROID 288 258 3 48
HYDROCHLOROTHIAZIDE 229 203 4 12
LISINOPRIL 227 193 5 5
PRAVASTATIN SODIUM 221 179 6 11
SIMVASTATIN 210 184 7 6
ATORVASTATIN CALCIUM 210 191 7 20
LEVOTHYROXINE SODIUM 209 203 9 7
MELOXICAM 177 157 10 13
METFORMIN HCL 166 156 11 8
HYDROCODONE-ACETAMINOPHEN 154 126 S3 12 1
FUROSEMIDE 146 114 13 4
FLUOXETINE HCL 143 121 14 70
CITALOPRAM HBR 142 112 15 17
LOSARTAN POTASSIUM 136 128 16 34
METOPROLOL SUCCINATE 134 119 17 14
GLIMEPIRIDE 116 104 18 30
ZOLPIDEM TARTRATE 111 86 19 21
AMLODIPINE BESYLATE-BENAZEPRIL 109 93 20 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 88 21 16
ESCITALOPRAM OXALATE 101 87 21 73
CRESTOR 95 95 23 29
SERTRALINE HCL 93 71 24 26
CYMBALTA 85 60 25 47
METOPROLOL TARTRATE 83 70 26 22
LOSARTAN-HYDROCHLOROTHIAZIDE 82 61 27 51
BENAZEPRIL HCL 74 62 28 58
POTASSIUM CHLORIDE 72 56 29 9
FLUTICASONE PROPIONATE 69 56 30 49
GABAPENTIN 67 58 31 10
AMITRIPTYLINE HCL 65 38 R 32 46
TAMSULOSIN HCL 64 37 33 38
PANTOPRAZOLE SODIUM 64 52 33 42
ROPINIROLE HCL 58 44 35 85
AZITHROMYCIN 58 50 35 39
TRAZODONE HCL 58 45 35 36
LOVASTATIN 54 54 38 33
IRBESARTAN 54 48 38 284
NEXIUM 54 52 38 23
METHYLPREDNISOLONE 53 45 41 124
DONEPEZIL HCL 52 52 42 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.